Sartorius Aktiengesellschaft Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 16 Fair Values set on narratives written by author
SRT3 Community Narratives
Advanced Biologic Adoption Will Expand Global Reach
Rising Tariffs, Regulatory Hurdles And Cost Pressures Will Squeeze Margins
Cell And Gene Therapies Will Expand Secular Bioproduction
Rising Tariffs, Regulatory Hurdles And Cost Pressures Will Squeeze Margins
View narrativeCell And Gene Therapies Will Expand Secular Bioproduction
View narrativeAdvanced Biologic Adoption Will Expand Global Reach
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
Rising Tariffs, Regulatory Hurdles And Cost Pressures Will Squeeze Margins
Cell And Gene Therapies Will Expand Secular Bioproduction
Advanced Biologic Adoption Will Expand Global Reach
Snowflake Analysis
Sartorius Aktiengesellschaft Key Details
- 2.84
- 45.71%
- 5.48%
- 96.4%
About SRT3
- Founded
- 1870
- Employees
- 14279
- CEO
- Website
View website
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.